Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Hepatitis B Vaccine (Hansenula) in Newborns of HBsAg/HBeAg-Positive Mothers
CTR20132239Phase 3Active
- Sponsor
- Hualan Biological Vaccine
- Start
- Jan 2014
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant hepatitis b vaccine (hansenula polymorpha) in hepatitis B (HBV), sponsored by Hualan Biological Vaccine. Started Jan 2014; status: active.
02
Drugs
recombinant hepatitis b vaccine (hansenula polymorpha)
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on CTR20132239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132239.